D.E. Shaw & Co’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Sell |
613,059
-271,229
| -31% | -$993K | ﹤0.01% | 1848 |
|
|
2025
Q1 | $3.82M | Buy |
884,288
+146,845
| +20% | +$634K | ﹤0.01% | 1495 |
|
|
2024
Q4 | $2.36M | Sell |
737,443
-672
| -0.1% | -$2.15K | ﹤0.01% | 1714 |
|
|
2024
Q3 | $2.11M | Sell |
738,115
-3,818
| -0.5% | -$10.9K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $2.08M | Buy |
741,933
+109,189
| +17% | +$306K | ﹤0.01% | 1780 |
|
|
2024
Q1 | $1.8M | Sell |
632,744
-334,128
| -35% | -$949K | ﹤0.01% | 1840 |
|
|
2023
Q4 | $3.95M | Sell |
966,872
-119,346
| -11% | -$488K | ﹤0.01% | 1350 |
|
|
2023
Q3 | $3.45M | Sell |
1,086,218
-184,747
| -15% | -$587K | ﹤0.01% | 1413 |
|
|
2023
Q2 | $4.22M | Sell |
1,270,965
-69,878
| -5% | -$232K | ﹤0.01% | 1341 |
|
|
2023
Q1 | $2.86M | Buy |
1,340,843
+909,003
| +210% | +$1.94M | ﹤0.01% | 1656 |
|
|
2022
Q4 | $1.16M | Buy |
431,840
+237,062
| +122% | +$638K | ﹤0.01% | 2333 |
|
|
2022
Q3 | $631K | Buy |
194,778
+43,523
| +29% | +$141K | ﹤0.01% | 2765 |
|
|
2022
Q2 | $738K | Buy |
151,255
+87,490
| +137% | +$427K | ﹤0.01% | 2838 |
|
|
2022
Q1 | $486K | Sell |
63,765
-12,740
| -17% | -$97.1K | ﹤0.01% | 3222 |
|
|
2021
Q4 | $707K | Sell |
76,505
-56,812
| -43% | -$525K | ﹤0.01% | 2925 |
|
|
2021
Q3 | $1.9M | Buy |
133,317
+88,723
| +199% | +$1.26M | ﹤0.01% | 2126 |
|
|
2021
Q2 | $741K | Buy |
+44,594
| New | +$741K | ﹤0.01% | 2686 |
|